MedTrace Logo

Clinical Evaluation of Radiation Reduction for Optimized Safety

NCT06348875 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-11-13

No results posted yet for this study

Summary

The primary objective of this study is to determine whether a reduced radiation protocol (RRP) in which angiograms are acquired at ultralow radiation doses and then processed using spatiotemporal enhancement software can produce similar quality angiographic images as compared with standard techniques.

Conditions

Sponsors & Collaborators

  • Angiowave Imaging

    lead INDUSTRY

Principal Investigators

  • Aram Salzman · Angiowave Imaging

  • Sean Madden, PhD · Angiowave Imaging

  • Ryan Madder, MD · Corewell Health

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-15
Primary Completion
2026-06-15
Completion
2026-07-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06348875 on ClinicalTrials.gov